The results showed DNMT inhibition increased the tumor infiltration of CD3, CD4, and CD8 T cells as well as decreased the expression levels of immunosuppressive factors, such as PAK2 and VISTA, compared to the control group. The gene discussed is CD8A; the disease is neoplasm.